50% Off! Beat the market in 2025 with InvestingProCLAIM SALE

CVS faces lawsuit over illegal opioid prescriptions

Published 12/18/2024, 03:36 PM
© Reuters.
CVS
-

Investing.com -- The U.S. Department of Justice (DOJ) announced on Wednesday a lawsuit against CVS, accusing the pharmacy giant of filling and billing federal health insurance programs for illegal opioid prescriptions, a practice that has contributed to a nationwide opioid addiction and overdose crisis.

The lawsuit, recently unsealed in a federal court in Providence, Rhode Island, alleges that CVS has been involved in this illicit activity since October 2013. The DOJ claims that CVS filled prescriptions for hazardous quantities of opioids, provided early refills, and combined dangerous drugs, all in violation of the federal Controlled Substances Act.

According to the DOJ, these violations were motivated by company-enforced performance metrics. In certain instances, patients tragically died of overdoses shortly after filling these illegal prescriptions.

In response to the lawsuit, CVS has strongly contested the allegations. The company stated, "We have cooperated with the DOJ's investigation for more than four years, and we strongly disagree with the allegations and false narrative within this complaint." The outcome of this lawsuit is yet to be determined.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.